Cardinal Health’s First-Quarter Fiscal 2023 Earnings: What to Expect

Trending News 🌥️

Cardinal Health ($NYSE:CAH) is a publicly traded company that provides various products and services related to the healthcare industry. The company is expected to release its first-quarter fiscal 2023 earnings on May. Investors can expect the company to report revenue and earnings growth compared to the same period last year. The company is also benefiting from recent acquisitions, cost-cutting measures, and favorable currency exchange rates.

Cardinal Health’s stock has performed well in recent months, and the company’s strong first-quarter results could help continue this positive momentum. Investors will also be looking for any updates on the company’s plans to spin off its clinical and medical products businesses.

Earnings

Cardinal Health is a leading healthcare services and products company. They are set to release their first-quarter fiscal 2023 earnings report on August. In their last earning report for fiscal year 2022, ending June 30, they earned a total revenue of 181364.0 million dollars and lost 933.0 million dollars in net income. Compared to the previous year, this is an 11.6% increase in total revenue and a 252.7% decrease in net income.

Despite the decrease in net income, their total revenue has still grown significantly, reaching from 152922.0 million dollars to 181364.0 million dollars in the last three years. Investors will be closely watching Cardinal Health’s first-quarter earnings report to see if the company can rebound from the loss in net income. They will also be interested in seeing if the company’s total revenue continues to grow.

Price History

ET to discuss the results. Cardinal Health‘s earnings per share have declined by an average of 12% over the last four quarters. The company’s revenue has declined by an average of 2% over the last four quarters. Cardinal Health is a global, integrated healthcare services and products company, providing tailored solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company operates in two segments: Pharmaceutical and Medical.

The Pharmaceutical segment distribute branded and generic pharmaceutical and over-the-counter healthcare products, including medical-surgical supplies and laboratory supplies, to wholesalers, retail drug stores, mail order pharmacies, hospitals, clinics and other alternate care sites. This segment also provides nuclear pharmacy services to the nuclear medicine physicians. The Medical segment provides medical products and services to hospitals, physician offices and other alternate care sites, including surgical products and services, anesthesia products, capital equipment and related services, and diagnostic products and services.

VI Analysis

Cardinal Health is a large healthcare company with a presence in both the United States and Europe. The company’s fundamentals reflect its long term potential, and VI app gives a clear picture of the company’s financial and business risks. Based on the VI Risk Rating, Cardinal Health is a medium risk investment in terms of financial and business aspects.

However, the VI App has detected 1 risk warning in the income sheet. Register on vi.app to check it out.

VI Peers

Its competitors are AmerisourceBergen Corp, McKesson Corp, and Sigma Healthcare Ltd.

– AmerisourceBergen Corp ($NYSE:ABC)

AmerisourceBergen Corp is a drug wholesaler that was founded in 1985. The company has a market cap of 32.4B as of 2022 and a return on equity of 417.0%. AmerisourceBergen Corp distributes prescription drugs and other healthcare products and services to healthcare providers and pharmaceutical companies. The company operates in two segments, Pharmaceutical Distribution and Other.

– McKesson Corp ($NYSE:MCK)

McKesson Corp is a healthcare services and information technology company. It has a market cap of 55.96B as of 2022 and a Return on Equity of -74.43%. The company provides a range of services and products to healthcare providers, payers, and consumers. These services and products include prescription drugs, medical supplies, and software and technology solutions.

– Sigma Healthcare Ltd ($ASX:SIG)

Sigma Healthcare Ltd is a pharmaceutical company with a market cap of 683.23M as of 2022 and a ROE of 0.46%. The company manufactures and distributes a range of prescription and over-the-counter medicines, medical devices, and other healthcare products.

Summary

Cardinal Health is a health care services and products company that operates in two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter health care, and consumer products. The Medical segment manufactures and distributes medical, surgical, and laboratory products.

The company has a strong balance sheet and generates significant cash flow, which provides it with the ability to continue to invest in its business and return cash to shareholders. Cardinal Health is a leader in the health care industry, and its stock is a compelling investment for long-term investors.